Effect of HTK solution in liver transplantatio
Phase 3
- Conditions
- Organ transplantation.Transplanted organ and tissue status
- Registration Number
- IRCT20200106046029N1
- Lead Sponsor
- Pharmed Cina Caspian Pouyesh Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Patient undergoing liver transplantation
Age above 18 years old
Informed consent to enter the study
Exclusion Criteria
Those with organ donations from outside of the province
Pregnant patients or those who are lactating
Those with donations after cardiac death (DCD)
Those who are undergoing re-transplantations
Those with machine perfusion
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary non-function of organ. Timepoint: 30 days after transplantation. Method of measurement: Blood tests and pathology biopsy.
- Secondary Outcome Measures
Name Time Method Changes in AST and ALT on the first day after transplantation up to discharge. Timepoint: One day after transplantation up to discharge. Method of measurement: Blood test.;Acute rejection during first month. Timepoint: One month after transplantation. Method of measurement: Blood tests and pathology biopsy.;Early patient survival (3 months). Timepoint: Three months after transplantation. Method of measurement: Follow-up of patients and hospital records.;Biliary complications. Timepoint: Three months after transplantation. Method of measurement: follow-up sonography.